Aurinia Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aurinia Pharmaceuticals generated cash of -$33,461,000, which is more than the previous year. Cash used in financing activities reached the amount of -$5,130,000 last year. Net change in cash is therefore -$45,297,000.
Cash Flow
| 2014 | -16.90M | -10.08M | 47.89M |
|---|---|---|---|
| 2015 | -17.76M | -23K | 839K |
| 2016 | -18.71M | 9.99M | 42.61M |
| 2017 | -41.16M | -8.00M | 175.15M |
| 2018 | -51.61M | -66K | 4.01M |
| 2019 | -63.45M | 7.78M | 243.72M |
| 2020 | -69.85M | -158.18M | 194.37M |
| 2021 | -157.69M | -103.87M | 221.11M |
| 2022 | -79.52M | -60.63M | 2.43M |
| 2023 | -33.46M | -6.70M | -5.13M |
AUPH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 94.17M | 231.9M | 272.35M | 306.01M | 117.96M | 165.62M | 39.64M | 5.75M | 22.70M | 1.82M |
Operating activities | ||||||||||
Net income | -78.02M | -108.18M | -180.96M | -102.68M | -123.84M | -64.12M | -70.79M | -23.29M | -18.60M | -16.64M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 11.64M | 2.70M | 2.76M | 1.37M | 1.54M | 1.56M | 1.45M | 1.47M | 1.55M | 1.52M |
Stock-based compensation expense | 45.31M | 32.3M | 31.24M | 17.45M | 7.41M | 0 | 4.24M | 1.38M | 3.22M | 2.18M |
| Deferred income tax benefit | 45.31M | 32.3M | 31.24M | 17.45M | 7.41M | 0 | 4.24M | 1.38M | 3.22M | 2.18M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -10.60M | 1.92M | -15.41M | -13.62M | -151K | 0 | -23K | -39K | 45K | 9K |
Inventories | -15.86M | -9.07M | -5.64M | -13.92M | -3.85M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 13.39M | 699K | 4.07M | 13.62M | 4.00M | 0 | 2.16M | 0 | 869K | -1.50M |
Cash generated by operating activities | -33.46M | -79.52M | -157.69M | -69.85M | -63.45M | -51.61M | -41.16M | -18.71M | -17.76M | -16.90M |
Investing activities | ||||||||||
Purchases Of Investments | -523.5M | -523.99M | -438.95M | -202.95M | 0 | -36.08M | -97.99M | -21.13M | -19.98M | -9.99M |
Investments In Property Plant And Equipment | -718K | -292K | -1.50M | -7.34M | -104K | -75K | -25K | -25K | -50K | -90K |
Acquisitions Net | 0 | 0 | -1.20M | 1.75M | 0 | 45K | 0 | 10K | 44K | 0 |
Cash generated by investing activities | -6.70M | -60.63M | -103.87M | -158.18M | 7.78M | -66K | -8.00M | 9.99M | -23K | -10.08M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 2.43M | 196.74M | 187.73M | 223.11M | 0 | 166.46M | 0 | 839K | 48.30M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -10.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.6M |
Cash used in financing activities | -5.13M | 2.43M | 221.11M | 194.37M | 243.72M | 4.01M | 175.15M | 42.61M | 839K | 47.89M |
Net Change In Cash | -45.29M | -137.72M | -40.45M | -33.66M | 188.05M | -47.66M | 125.98M | 33.89M | -16.95M | 20.88M |
Cash at end of period | 48.87M | 94.17M | 231.9M | 272.35M | 306.01M | 117.96M | 165.62M | 39.64M | 5.75M | 22.70M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |